Abstract
Glyconanoparticles are very useful tools for proteomic and glycomics research. They mainly contain glycosylated gold nanoparticles, glycosylated quantum dots, and magnetic glyconanoparticles. This review summarized the glyconanoparticle progress on biolabeling, in vitro or in vivo imaging, biosensing, targeted drug delivery, and other biomedical applications in recent years. The core of glyconanoparticle applications is to study the carbohydrate-mediated interactions, which opens the new field in glycobiology.
Keywords: Gold glyconanoparticles, glycosylated quantum dots, magnetic glyconanoparticles, applications, proteomic, glycomics research, targeted drug delivery, biosensing, carbohydrate-mediated interactions, glycobiology
Current Pharmaceutical Design
Title:Recent Progress on the Applications of Multifunctional Glyconanoparticles
Volume: 19 Issue: 13
Author(s): Gangliang Huang, Fei Cheng, Xin Chen, Daquan Peng, Xiancheng Hu and Guoming Liang
Affiliation:
Keywords: Gold glyconanoparticles, glycosylated quantum dots, magnetic glyconanoparticles, applications, proteomic, glycomics research, targeted drug delivery, biosensing, carbohydrate-mediated interactions, glycobiology
Abstract: Glyconanoparticles are very useful tools for proteomic and glycomics research. They mainly contain glycosylated gold nanoparticles, glycosylated quantum dots, and magnetic glyconanoparticles. This review summarized the glyconanoparticle progress on biolabeling, in vitro or in vivo imaging, biosensing, targeted drug delivery, and other biomedical applications in recent years. The core of glyconanoparticle applications is to study the carbohydrate-mediated interactions, which opens the new field in glycobiology.
Export Options
About this article
Cite this article as:
Huang Gangliang, Cheng Fei, Chen Xin, Peng Daquan, Hu Xiancheng and Liang Guoming, Recent Progress on the Applications of Multifunctional Glyconanoparticles, Current Pharmaceutical Design 2013; 19 (13) . https://dx.doi.org/10.2174/1381612811319130014
DOI https://dx.doi.org/10.2174/1381612811319130014 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synergy Against Fungal Pathogens: Working Together is Better Than Working Alone
Current Medicinal Chemistry The Use of Nimesulide and Its Analogues in Cancer Chemoprevention
Anti-Cancer Agents in Medicinal Chemistry Editorial [Hot Topic: IgG4-Related Disease: A Unique and Emerging Entity (Guest Editors: Susumu Sugai, Shigeyuki Kawa, Yoh Zen)]
Current Immunology Reviews (Discontinued) Polysaccharide-K (PSK) in Cancer - Old Story, New Possibilities?
Current Medicinal Chemistry Metacaspases, Autophagins and Metallocarboxypeptidases: Potential New Targets for Chemotherapy of the Trypanosomiases
Current Medicinal Chemistry The Concept of a Green Drug, Curcumin and It ’ s Derivatives as a Model System
Mini-Reviews in Organic Chemistry Biomarkers and Multiple Drug Resistance in Breast Cancer
Current Cancer Drug Targets Design of Lipophilic Prodrugs to Improve Drug Delivery and Efficacy
Current Drug Targets Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
Current Drug Targets Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design
Current Drug Targets Anti-Cancer Therapy: Targeting the Mevalonate Pathway
Current Cancer Drug Targets Interactions of Curcumin and Its Derivatives with Nucleic Acids and their Implications
Mini-Reviews in Medicinal Chemistry Treatment of Anaplastic Thyroid Cancer: Is there a Role for PPARγ Agonists?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2-Aminoimidazole, Glycociamidine and 2-Thiohydantoin-Marine Alkaloids as Molecular Inspirations for the Development of Lead Structures
Current Drug Targets Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?
Current Cancer Drug Targets Follicular Immunology Environment and the Influence on In Vitro Fertilization Outcome
Current Women`s Health Reviews Lumiflavin Enhances the Effects of Ionising Radiation on Ovarian Cancer Stem-Like Cells by Inhibiting Autophagy
Anti-Cancer Agents in Medicinal Chemistry Apoptosis in Drug Response
Current Pharmacogenomics Intravesical Drug Delivery into the Bladder to Treat Cancers
Current Drug Delivery DNMT Inhibitors in Cancer, Current Treatments and Future Promising Approach: Inhibition of Specific DNMT-Including Complexes
Epigenetic Diagnosis & Therapy (Discontinued)